Respiratory virus season has arrived, and hopefully you’re up to date on vaccinations that can help prevent infectious ...

A new study shows that the addition of respiratory syncytial virus (RSV) to Minnesota’s viral genomic surveillance program ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

The term “immunity debt” is being used to describe how countries are seeing an increase in viral infections, particularly ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or ...

RSV vaccination was associated with decreased risks for infection and hospitalization, although the decrease was not statistically significant.

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

What is this silent virus that endangers Filipino Seniors with comorbidities? Respiratory Syncytial Virus (RSV) is not just another cold or flu—it is potentially life- threatening for ...

Clesrovimab is an extended half-life RSV neutralizing antibody in development for all infants in their first RSV season and ...

(Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory ...